Director, MedStar Georgetown Headache Center, and associate professor of neurology, MedStar Georgetown University Hospital
Providing Optimal Management for Migraine Amid a Growing Treatment Landscape: Jessica Ailani, MD
The director of the MedStar Georgetown Headache Center discussed the importance of a healthy clinician-patient relationship and the conversations needed during treatment selection for migraine. [WATCH TIME: 4 minutes]
Promise in PACAP Pathway for Treating Migraine: Jessica Ailani, MD
The director of the MedStar Georgetown Headache Center provided insight on the excitement behind PACAP, how it may offer an alternate way of treating migraine, and where research behind it currently stands. [WATCH TIME: 4 minutes]
Medical Crossfire on the Paradigm Shifts in Migraine Therapy: Jessica Ailani, MD
The director of the MedStar Georgetown University Hospital Headache Center tells her experience in a medical crossfire as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]
The Benefits of Cross-Specialty Interaction at IFN 2022: Jessica Ailani, MD
The director of the MedStar Georgetown University Hospital Headache Center shares her experience as the migraine cochair at the fourth annual International Congress on the Future of Neurology. [WATCH TIME: 5 minutes]
New Treatments in Migraine: An In-Depth Review
Although new treatments and innovations are a sign of growth in migraine care, it is important to realize that growth comes with a certain amount of pain. In clinical practice, choosing the right treatment option for patients in a time-limited visit is often a dilemma.
Future Directions for the Management of Migraine
Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.
Emerging Therapies for Migraine
Experts in headache medicine review novel therapeutic agents under investigation and the evolving treatment landscape for migraine.
Assessing Treatment Response and Efficacy for Migraine Therapy
Julio R. Vieira, MD, leads a discussion on the importance of follow-up visits for patients with migraine and considerations for switching therapies.
CGRP Monoclonal Antibodies for Preventive Treatment of Migraine
Andrew C. Charles, MD; Bradley Torphy, MD; and Jessica Ailani, MD, review current FDA approved CGRP monoclonal antibodies available for the preventive treatment of migraine.
Using CGRP Antagonists for the Treatment of Migraine
Experts in headache medicine discuss the role of CGRP-based therapy for migraine prevention.
AHS and NHF Consensus Statements for Migraine
Drs Bradley Torphy and Jessica Ailani share thoughts on using consensus statements to guide the treatment of migraine.
Acute and Preventive Treatment Options for Migraine
Sait Ashina, MD, reviews current AHS (American Headache Society) treatment recommendations for the acute and preventive treatment of migraine.
Acute Versus Preventative Treatment of Migraine
Dr Julio R. Vieira defines acute versus preventive treatment for migraine and highlights the differences in goals of therapy for each.
Approaching the Treatment of Migraine
Sait Ashina, MD, and Jessica Ailani, MD, comment on the importance of individualized treatment regimens for the management of migraine.
Using Diagnostic Tools to Assess Migraine
Experts in neurology, Drs Julio R. Vieira, Jessica Ailani, and Bradley Torphy review diagnostic tools available for migraine, including patient use of headache diaries.
Differentiating Migraine From Other Headache Disorders
Jessica Ailani, MD, and Bradley Torphy, MD, discern the signs of migraine and comment on the importance of ensuring accurate diagnosis for patients.
Challenges of Migraine Diagnosis
Drs Bradley Torphy and Julio R. Vieira share insight on approaching the diagnosis of migraine as well as current challenges in diagnosis.
Reducing Clinical Burden of Migraine
Andrew C. Charles, MD; Jessica Ailani, MD; and Sait Ashina, MD, discuss the impact of migraine on a patient’s quality of life and share strategies for reducing the clinical burden of disease.
Pathophysiology of Migraine
Andrew C. Charles, MD, and Sait Ashina, MD, provide an overview of the pathophysiology of migraine and discuss its 5 clinical phases.
The Changing Landscape of Preventative Migraine Treatments
A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Headache Specialists for Preventative Migraine Treatments
A discussion on when a patient should be referred to a headache specialist for preventive migraine treatment.
Preventative Migraine Therapies: The ADVANCE Trial and the Future
Jessica Ailani, MD, details how the phase 3 ADVANCE trial will shape the research of future agents for preventive migraine treatment.
Oral Agents for Preventative Migraine Treatment
A key opinion leader discusses the use of oral agents for the preventive treatment of migraine.
CGRP Monoclonal Antibodies and Patient Treatment Selection
Dr Christopher Gottschalk shares how the clinical trial data for CGRP monoclonal antibodies affect patient selection for preventive migraine treatment.
CGRP Monoclonal Antibodies: A Review of Trial Data
A panel of neurologists review clinical trial data on several CGRP monoclonal antibodies for migraine preventive treatment.
Preventing Migraine with CGRP Monoclonal Antibodies
Expert neurologists discuss the use of CGRP monoclonal antibodies to prevent migraines.
OnabotulinumtoxinA for Preventative Migraine Treatment
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN, provides an overview of the use of onabotulinumtoxinA as a preventive migraine treatment.
Discussing Novel Agents for Preventative Migraine Therapy with Patients
A thought leader explains how she involves the patient when selecting novel agents to add to a preventive migraine treatment plan.
Preventative Migraine Therapy: Novel Agents
An introduction to the use of novel agents for preventive migraine therapy.
Behavioral Treatment Strategies for Migraine Management
An expert panel discusses migraine prevention with the use of behavioral therapies such as cognitive behavioral therapy and stress management.
2 Clarke Drive Cranbury, NJ 08512